Skip to main content
Clinical Trials/NL-OMON23610
NL-OMON23610
Recruiting
Not Applicable

Skeletal muscle glucose transport and mitochondrial function in type 1 diabetes

Vrije Universiteit Amsterdam0 sites32 target enrollmentTBD
ConditionsType 1 diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 1 diabetes
Sponsor
Vrije Universiteit Amsterdam
Enrollment
32
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, participants with T1DM must meet all of the following criteria:
  • Individuals with T1DM with a diagnosed disease duration of 1 – 45 years
  • Male or female
  • Aged between 18\-65 years
  • In order to be eligible to participate in this study, healthy control participants must meet all of the following criteria:
  • No chronic health conditions and between the ages of 18\-65

Exclusion Criteria

  • History of asthma, stroke, chronic obstructive pulmonary disease, congestive heart failure, heart surgery, or congenital heart diseases
  • Current treatment with drugs known to interfere with metabolism e.g. systemic corticosteroids, statins, SGLT2 inhibitors, GLP1 receptor agonists
  • Are current smokers or have been a regular smoker within the last 12 months
  • Insulin pump therapy
  • Symptomatic autonomic or distal neuropathy
  • BMI \>30 due to adiposity, since this is known to cause difficulties in obtaining muscle biopsies.
  • Recent acute myocardial infarction (\<6 months)
  • Uncontrolled arrhythmia/severe conduction disorder (atrial fibrillation or second/third degree AV block) causing hemodynamic compromise
  • Implantable pacemaker or other cardiac device with complete ventricular pacing
  • Uncontrolled heart failure with hemodynamic compromise

Outcomes

Primary Outcomes

Not specified

Similar Trials